Analysts' Actions: Express Scripts, JDS Uniphase, Omnicare and More

NEW YORK (TheStreet) -- RATINGS CHANGES

CME (CME) was initiated with a buy rating at Deutsche Bank. Twelve-month price target is $85. Company is leveraged to higher trading volume, especially in futures, Deutsche Bank said.

Express Scripts (ESRX) was downgraded at Goldman Sachs to neutral from buy. Twelve-month price target is $75. Core business is facing fading growth drivers, Goldman said.

Frank's International (FI) was initiated with a sell rating at TheStreet Ratings.

JDS Uniphase (JDSU) was upgraded at RBC Capital to outperform from sector perform. Twelve-month price target of $18 based on a sum-of-the-parts valuation, RBC Capital said.

Jones Lang Lasalle (JLL) was upgraded at J.P. Morgan to overweight from neutral. Estimates were also increased, given strong asset pricing and rental demand, J.P. Morgan said.

Macy's (M) was downgraded at Sterne Agee to neutral from buy. Twelve-month price target is $62. Valuation call, as yellow flags have recently emerged, Sterne Agee said.

Medtronic (MDT) was initiated with a neutral rating at Sterne Agee. Twelve-month price target is $68. Company lacks near-term catalysts, Sterne Agee said.

Nasdaq OMX (NDAQ) was initiated with a hold rating at Deutsche Bank. Valuation call, based on a 12-month price target of $46, Deutsche Bank said.

Nortel Inversora (NTL) was downgraded to hold at TheStreet Ratings.

Omnicare (OCR) was upgraded at Goldman Sachs to buy. Twelve-month price target is $76. Generic business can drive growth and the company has untapped strategic value, Goldman said.

Twitter (TWTR) was initiated with a buy rating at Canaccord Genuity. Twelve-month price target is $62. Newer ad products should lead to faster monetization, Canaccord Genuity said.

Wesco (WCC) was upgraded at J.P. Morgan to overweight from neutral. Consensus estimates should be near a floor and end-market demand is improving, J.P. Morgan said.

Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.

Follow TheStreet on Twitter and become a fan on Facebook.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

More from Stocks

Listen: Should You Buy Cisco Now?

Listen: Should You Buy Cisco Now?

Amazon Could Devastate Walgreens and Rite Aid by Getting Into Pharmacy Business

Amazon Could Devastate Walgreens and Rite Aid by Getting Into Pharmacy Business

Amazon's Assault on Grocery Stores Will Have a Profound Impact on Many

Amazon's Assault on Grocery Stores Will Have a Profound Impact on Many

Why PayPal's CEO Doesn't Fear Amazon Entering Mobile Payments

Why PayPal's CEO Doesn't Fear Amazon Entering Mobile Payments

9 Stocks Goldman Sachs Thinks Will Blow Wall Street's Performance Away in 2019

9 Stocks Goldman Sachs Thinks Will Blow Wall Street's Performance Away in 2019